A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial. - Fonteneau C; Tamayo Z; Price A; Pan L; Afriyie-Agyemang Y; Agrawal S; Butler A; Cail C; Calkins M; Chakilam AR; Forselius-Bielen K; Fram G; et al. (Journal of psychiatric research, 2026)